Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic screening for pharmaceuticals using tissue constructs.

Current pharmaceutical biotechnology - 1 Apr 2004

Wakatsuki T, Fee J A, Elson E L

Abstract excerpt

Compounds can be screened for pharmaceutical activity either by detecting interactions with specified target molecules such as receptors or enzymes (molecular screening) or observing effects on the structure or physiological activities of cells or tissues (phenotypic screening). Screening at the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Evaluation, Preclinical
Share to Drugs, Investigational
Share to Extracellular Matrix

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Muscle, Skeletal

Share to Myocytes, Cardiac

Share to Myocytes, Smooth Muscle

Share to Tissue Engineering

Source

Identifiers

PMID: 15078152
DOI: 10.2174/1389201043376940

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15078152-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic screening for pharmaceuticals using tissue constructs.PMID 15078152Read ↗

FLECS Technology for High-Throughput Screening of Hypercontractile Cellular Phenotypes in Fibrosis: A Function-First Approach to Anti-Fibrotic Drug DiscoverySemantic proximity Read ↗

Design of phenotypic screens for bioactive chemicals and identification of their targets by genetic and proteomic approaches.Semantic proximity Read ↗

FLECS technology for high-throughput screening of hypercontractile cellular phenotypes in fibrosis: A function-first approach to anti-fibrotic drug discovery.Semantic proximity Read ↗

The application of phenotypic high-throughput screening techniques to cardiovascular research.Semantic proximity Read ↗

The Scar-in-a-Jar: In Vitro Fibrosis Model for Anti-Fibrotic Drug Testing.Semantic proximity Read ↗

The Power of Sophisticated Phenotypic Screening and Modern Mechanism-of-Action Methods.Semantic proximity Read ↗

Label-Free Cell Phenotypic Assays for Assessing Drug Polypharmacology.Semantic proximity Read ↗

Cell and small animal models for phenotypic drug discovery.Semantic proximity Read ↗

Phenotypic Screening of Drug Library in Actively Differentiating Mouse Embryonic Stem Cells.Semantic proximity Read ↗

High content screening for modulators of cardiac differentiation in human pluripotent stem cells.Semantic proximity Read ↗

A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules.Semantic proximity Read ↗

Label-free cell phenotypic drug discovery.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.